Accomplishments in 2007 in the Adjuvant Treatment of Colorectal Cancer

Por de Gramont, Aimery, Haller, Daniel G.
Publicado em 2008

Accomplishments in Gastrointestinal Oncology in 2007: Conclusion

Por de Gramont, Aimery, Haller, Daniel G.
Publicado em 2008

Therapeutic strategy in unresectable metastatic colorectal cancer

Por Chibaudel, Benoist, Tournigand, Christophe, André, Thierry, de Gramont, Aimery
Publicado em 2012

Update on Targeted Agents for Adjuvant Treatment of Colon Cancer in 2006

Por de Gramont, Aimery, Larsen, Annette K., Tournigand, Christophe, Louvet, Christophe, André, Thierry
Publicado em 2007

The ARCAD Clinical Trials Program: An Update and Invitation

Por Sargent, Daniel J., Buyse, Marc, Matheson, Alastair, Goldberg, Richard M., de Gramont, Aimery
Publicado em 2012

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

Por Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery
Publicado em 2008

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by ninteda...

Por Mésange, Paul, Poindessous, Virginie, Sabbah, Michèle, Escargueil, Alexandre E., de Gramont, Aimery, Larsen, Annette K.
Publicado em 2014

Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review

Por Chibaudel, Benoist, Tournigand, Christophe, Bonnetain, Franck, Richa, Hubert, Benetkiewicz, Magdalena, André, Thierry, de Gramont, Aimery
Publicado no Ther Adv Med Oncol (2015)

Current Status of Adjuvant Therapy for Colon Cancer

Por André, Thierry, Afchain, Pauline, Barrier, Alain, Blanchard, Pierre, Larsen, Annette K., Tournigand, Christophe, Louvet, Christophe, de Gramont, Aimery
Publicado em 2007

Accomplishments in 2008 in the Adjuvant Treatment of Colon Cancer

Por Marshall, John L., de Gramont, Aimery, Köhne, Claus-Henning, Marshall, J.L., de Gramont, A., Köhne, C.-H.
Publicado em 2009

Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology

Por Marshall, John L., Haller, Daniel G., de Gramont, Aimery, Hochster, Howard S., Lenz, Heinz-Josef, Ajani, Jaffer A., Goldberg, Richard M.
Publicado em 2007

Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743

Por Soares, Daniele Grazziotin, Escargueil, Alexandre E., Poindessous, Virginie, Sarasin, Alain, de Gramont, Aimery, Bonatto, Diego, Henriques, João Antonio Pêgas, Larsen, Annette K.
Publicado em 2007

Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

Por Chibaudel, Benoist, Bonnetain, Franck, Tournigand, Christophe, Bengrine-Lefevre, Leila, Teixeira, Luis, Artru, Pascal, Desramé, Jérôme, Larsen, Annette K., André, Thierry, Louvet, Christophe, de Gramont, Aimery
Publicado em 2011

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

Por Blanke, Charles D., Bot, Brian M., Thomas, David M., Bleyer, Archie, Kohne, Claus-Henning, Seymour, Matthew T., de Gramont, Aimery, Goldberg, Richard M., Sargent, Daniel J.
Publicado no J Clin Oncol (2011)

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOL...

Por Hamidou, Zeinab, Chibaudel, Benoist, Hebbar, Mohamed, Hug de Larauze, Marine, André, Thierry, Louvet, Christophe, Brusquant, David, Garcia-Larnicol, Marie-Line, de Gramont, Aimery, Bonnetain, Franck
Publicado no PLoS One (2016)

Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set

Por Hubbard, Joleen, Thomas, David M., Yothers, Greg, Green, Erin, Blanke, Charles, O'Connell, Michael J., Labianca, Roberto, Shi, Qian, Bleyer, Archie, de Gramont, Aimery, Sargent, Daniel
Publicado em 2012

Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies

Por Sugihara, Kenichi, Ohtsu, Atsushi, Shimada, Yasuhiro, Mizunuma, Nobuyuki, Lee, Po-Huang, de Gramont, Aimery, Goldberg, Richard M., Rothenberg, Mace L., André, Thierry, Brienza, Silvano, Gomi, Katsushige
Publicado em 2011

Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy

Por Sinicrope, Frank A., Foster, Nathan R., Yothers, Greg, Benson, Al, Seitz, Jean Francois, Labianca, Roberto, Goldberg, Richard M., DeGramont, Aimery, O’Connell, Michael J., Sargent, Daniel J.
Publicado em 2013

Association of Age With Survival in Patients With Metastatic Colorectal Cancer: Analysis From the ARCAD Clinical Trials Program

Por Lieu, Christopher H., Renfro, Lindsay A., de Gramont, Aimery, Meyers, Jeffrey P., Maughan, Timothy S., Seymour, Matthew T., Saltz, Leonard, Goldberg, Richard M., Sargent, Daniel J., Eckhardt, S. Gail, Eng, Cathy
Publicado no J Clin Oncol (2014)

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Col...

Por Shah, Manish A., Renfro, Lindsay A., Allegra, Carmen J., André, Thierry, de Gramont, Aimery, Schmoll, Hans-Joachim, Haller, Daniel G., Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.
Publicado no J Clin Oncol (2016)